Evaluation of the treatment results of laryngeal carcinoma: our experience over 10 years

Basit Öğe Kaydı
dc.authoridBaglam, Tekin/0000-0001-5056-6852
dc.authoridKanlikama, Muzaffer/0000-0002-3537-7778
dc.authoriddurucu, cengiz/0000-0001-7607-6421
dc.authorwosidbaysal, elif/AAH-6406-2019
dc.authorwosidBaglam, Tekin/KHU-4616-2024
dc.authorwosidKanlikama, Muzaffer/AAG-8311-2020
dc.authorwosidbayazit, yildirim ahmet/GLR-7132-2022
dc.authorwosiddurucu, cengiz/HNR-2511-2023
dc.contributor.authorKaratas, Erkan
dc.contributor.authorBaysal, Elif
dc.contributor.authorDurucu, Cengiz
dc.contributor.authorBaglam, Tekin
dc.contributor.authorBayazit, Yildirim Ahmet
dc.contributor.authorKanlikama, Muzaffer
dc.date.accessioned2024-08-04T20:36:15Z
dc.date.available2024-08-04T20:36:15Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: To retrospectively analyze the treatment results for laryngeal carcinoma and to find the impact of the clinical parameters on the survival of the patients. Materials and methods: The medical records of 150 consecutive patients, operated on for laryngeal squamous cell carcinoma between 1991 and 2009, were reviewed. Tumor localization, TNM stages, treatment modalities, radiotherapy, second primary tumors, and tumor recurrence were recorded, and the survival data were obtained. Results: Neck metastasis was rare (3.6%) in T1 and T2 glottic tumors, while there was a significant increase in the rate of N+ neck (35%) in T3 and T4 glottic tumors (P < 0.05). N+ neck was encountered in 28% of the early and 33% of the late-stage supraglottic cancers (P > 0.05). There was a significant relation between survival and tumor recurrence (P < 0.05), whereas the other clinical parameters were not associated with survival (P > 0.05). The risk for death of the disease increased by 63.3% when tumor recurrence occurred (odds ratio = 6.3573). Conclusion: Aggressive treatment of the primary tumor and neck may eliminate the impact of advanced tumor stage on survival. Local and regional recurrence and second primary diagnosis are the most important factors involved in survival in laryngeal carcinoma.en_US
dc.identifier.doi10.3906/sag-1202-102
dc.identifier.endpage1399en_US
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.scopus2-s2.0-84870744960en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1394en_US
dc.identifier.urihttps://doi.org/10.3906/sag-1202-102
dc.identifier.urihttps://hdl.handle.net/11616/95880
dc.identifier.volume42en_US
dc.identifier.wosWOS:000321226500006en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherTubitak Scientific & Technological Research Council Turkeyen_US
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLaryngeal carcinomaen_US
dc.subjecttreatmenten_US
dc.subjectprognosisen_US
dc.subjectrecurrenceen_US
dc.subjectsurvivalen_US
dc.titleEvaluation of the treatment results of laryngeal carcinoma: our experience over 10 yearsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu